These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2619282)

  • 1. Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol.
    Lin TS; Schinazi R; Griffith BP; August EM; Eriksson BF; Zheng DK; Huang LA; Prusoff WH
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2149-51. PubMed ID: 2619282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol.
    Lin TS; Schinazi RF; Zhu J; Birks E; Carbone R; Si Y; Wu K; Huang L; Prusoff WH
    Biochem Pharmacol; 1993 Jul; 46(2):251-5. PubMed ID: 8347147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol.
    Royer RE; Mills RG; Deck LM; Mertz GJ; Vander Jagt DL
    Pharmacol Res; 1991 Dec; 24(4):407-12. PubMed ID: 1805194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1.
    An T; Ouyang W; Pan W; Guo D; Li J; Li L; Chen G; Yang J; Wu S; Tien P
    Antiviral Res; 2012 Jun; 94(3):276-87. PubMed ID: 22426469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
    Smith MS; Kessler JA; Rankin CD; Pagano JS; Kurtzberg J; Carter SG
    Antimicrob Agents Chemother; 1993 Jan; 37(1):144-7. PubMed ID: 8431013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro.
    Baba M; Ito M; Shigeta S; Tanaka H; Miyasaka T; Ubasawa M; Umezu K; Walker RT; De Clercq E
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1430-3. PubMed ID: 1929304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
    Schinazi RF; McMillan A; Cannon D; Mathis R; Lloyd RM; Peck A; Sommadossi JP; St Clair M; Wilson J; Furman PA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2423-31. PubMed ID: 1283296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.
    Levere RD; Gong YF; Kappas A; Bucher DJ; Wormser GP; Abraham NG
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1756-9. PubMed ID: 2000384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.
    Coates JA; Cammack N; Jenkinson HJ; Jowett AJ; Jowett MI; Pearson BA; Penn CR; Rouse PL; Viner KC; Cameron JM
    Antimicrob Agents Chemother; 1992 Apr; 36(4):733-9. PubMed ID: 1380229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine.
    Johnson VA; Walker BD; Barlow MA; Paradis TJ; Chou TC; Hirsch MS
    Antimicrob Agents Chemother; 1989 Jan; 33(1):53-7. PubMed ID: 2653214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV-1 activity of 3'-azido-3'-deoxythymidine (AZT) in primary mononuclear phagocytes.
    Beenhouwer DO; Rankin JA; Mellors JW
    Antiviral Res; 1992 Jul; 19(1):43-54. PubMed ID: 1444321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrations.
    Marschner IC; Mayers DL; Erice A; Smeaton L; Johnson VA; Richman DD; Reichelderfer P; Japour AJ
    J Clin Microbiol; 1997 Mar; 35(3):756-8. PubMed ID: 9041428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.
    Coates JA; Cammack N; Jenkinson HJ; Mutton IM; Pearson BA; Storer R; Cameron JM; Penn CR
    Antimicrob Agents Chemother; 1992 Jan; 36(1):202-5. PubMed ID: 1590690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HIV activity of 1,1'-dideoxygossypol and related compounds.
    Royer RE; Deck LM; Vander Jagt TJ; Martinez FJ; Mills RG; Young SA; Vander Jagt DL
    J Med Chem; 1995 Jun; 38(13):2427-32. PubMed ID: 7608907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 replication by nonionic block polymer surfactants.
    Hirschman SZ; Zucker ML; Garfinkel E
    J Med Virol; 1994 Mar; 42(3):249-54. PubMed ID: 8006638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.
    Pauwels R; Andries K; Debyser Z; Kukla MJ; Schols D; Breslin HJ; Woestenborghs R; Desmyter J; Janssen MA; De Clercq E
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2863-70. PubMed ID: 7535037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.
    Geleziunas R; Arts EJ; Boulerice F; Goldman H; Wainberg MA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1305-12. PubMed ID: 8392310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of water-soluble derivatives of chiral gossypol as HIV fusion inhibitors targeting gp41.
    Yang J; Li LL; Li JR; Yang JX; Zhang F; Chen G; Yu R; Ouyang WJ; Wu SW
    Bioorg Med Chem Lett; 2018 Jan; 28(1):49-52. PubMed ID: 29162455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
    Johnson VA; Barlow MA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.